Nuzenio

Tradingview Arcturus Therapeutics

Tradingview Arcturus Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Fri, 07 Aug 2026 17:20:05 GMTArcturus Therapeutics Holdings Inc. Stock 12‑Month Price Target Cut to $20.2, Implies 232% Upside - TradingView

Thu, 06 Aug 2026 22:04:08 GMTArcturus Therapeutics Q2 Earnings Call Highlights - TradingView

Thu, 06 Aug 2026 21:01:49 GMTArcturus Therapeutics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 20:35:07 GMTArcturus Therapeutics Holdings Inc. Q2 2026: Revenue $2.96M, EPS $(0.84) — 10-Q Summary - TradingView

Thu, 06 Aug 2026 20:13:22 GMTArcturus Therapeutics reports Q2 2026: $3.0M revenue, $23.8M net loss, $191.5M cash - TradingView

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Arcturus Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.